Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
analysts
Biotech
Bicara CEO: ASCO data resonate more with 'people that matter'
"Our data is resonating far more with the people that matter, which are the head and neck oncologists," Bicara's CEO told Fierce.
Gabrielle Masson
Jun 2, 2025 4:26pm
CROs should brace for continued slow Big Pharma demand: analyst
Jan 28, 2025 3:45pm
CRO and clinical trial markets set for growth by 2030: reports
Dec 4, 2024 3:15pm
In first, autoimmune patients respond to allogeneic CAR-T cells
Jul 17, 2024 3:26pm
Sanofi tries to quiet naysayers with data on Principia MS drug
Oct 14, 2021 10:05am
Pfizer stumbles close to finish line in growth hormone race
Sep 27, 2021 7:05am
